Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update
PMA submission targeted for Q1 2026 following positive Tigris results and ongoing FDA interactions Company to host Corporate Update call on Wednesday, December 10, 2025 TORONTO, Nov. 07, 2025 (GLOBE NEWSWIRE) — Spectral Medical Inc. ("Spectral" or the "Compan
(Financial Post, 2025-11-07T12:34:16Z)